Related Experiment Video
Updated: May 16, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Nuclear Smad7 Overexpressed in Mesenchymal Cells Acts as a Transcriptional Corepressor by Interacting with HDAC-1 and
Takashi Emori1, Koki Kitamura, Kenji Okazaki
1Present address: Department of Immunology and Inflammatory Diseases, Institute for Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan.
Abstract:
Smad family proteins are essential intracellular mediators that regulate transforming growth factor-β (TGF-β) ligand signaling. In response to diverse stimuli, Smad7 is rapidly expressed and acts as a cytoplasmic inhibitor that selectively interferes with signals elicited from TGF-β family receptors. In addition, earlier works have indicated that retrovirally transduced Smad7 induces long-lasting cell proliferation arrest in a variety of mesenchymal cells through down-regulation of G1 cyclins. However, the molecular mechanisms underlying the cytostatic effects of Smad7 remain unknown. We show here that Smad7 can form a complex with endogenous histone deacetylase proteins HDAC-1 and HDAC-3 in NIH 3T3 mouse fibroblast cells. By contrast, forced expression of a dominant-negative variant of HDAC-1 efficiently protected cells against Smad7 proliferation inhibition, suggesting that Smad7 depends on the deacetylase activity of its associated HDAC-1 to arrest the cell cycle. Furthermore, Smad7 caused HDAC-1 bind to E2F-1 to form a ternary complex on chromosomal DNA containing an E2F-binding motif and leading to repression in the activity of the E2F target genes. Smad7 mutations that prevented its binding to either HDAC-1 or E2F-1 resulted in a significant decrease in Smad7-mediated inhibition of cell proliferation. The present results strongly suggest that nuclear Smad7 is a transcriptional corepressor for E2F, providing a molecular basis for the Smad7-induced arrest of the cell cycle.
Insights
Smad7 inhibits cell proliferation by interacting with histone deacetylase proteins. This interaction leads to the formation of a complex that represses E2F target genes, causing cell cycle arrest.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Smad proteins mediate transforming growth factor-β (TGF-β) signaling.
- Smad7 acts as a cytoplasmic inhibitor of TGF-β family receptors.
- Smad7 induces cell proliferation arrest by down-regulating G1 cyclins.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying Smad7-induced cell proliferation arrest.
- To investigate the interaction of Smad7 with histone deacetylase (HDAC) proteins.
- To determine the role of Smad7-HDAC interaction in cell cycle regulation.
Main Methods:
- Co-immunoprecipitation to detect Smad7-HDAC complex formation.
- Use of dominant-negative HDAC-1 variant to assess Smad7's dependence on HDAC activity.
- Chromatin immunoprecipitation to analyze Smad7-HDAC-E2F-1 complex binding to DNA.
- Site-directed mutagenesis of Smad7 to study binding interactions.
Main Results:
- Smad7 forms complexes with HDAC-1 and HDAC-3 in NIH 3T3 cells.
- HDAC-1 deacetylase activity is essential for Smad7-mediated cell cycle arrest.
- Smad7 facilitates the binding of HDAC-1 to E2F-1 on DNA, forming a ternary complex.
- Mutations disrupting Smad7 binding to HDAC-1 or E2F-1 significantly reduce proliferation inhibition.
Conclusions:
- Nuclear Smad7 functions as a transcriptional corepressor for E2F.
- Smad7-HDAC interaction is a key mechanism for Smad7-induced cell cycle arrest.
- This study provides a molecular basis for Smad7's cytostatic effects.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
MAPK Signaling Cascades
TGF - β Signaling Pathway
Master Transcription Regulators
Mitogens and the Cell Cycle

